WHAT THIS STUDY ADDS: Late-onset hypocalcemia in neonates is often a sign of coexisting vitamin D deficiency and hypomagnesemia and is readily managed with therapy of limited duration, and neonates presenting with tetany or seizures due to hypocalcemia are unlikely to benefit from neuroimaging studies. RESULTS: Seventy-eight infants met criteria. Median (interquartile range) age at admission was 8.0 (7.0-10.0) days, and median duration of admission was 3.0 (2.0-4.0) days. Most infants were male (71.8%) and Hispanic (62.8%). Neonates were generally severely hypocalcemic and hyperphosphatemic. Seventy-five of 78 were hypomagnesemic, and the majority had low or inappropriately normal parathyroid hormone responses. Levels of 25-hydroxyvitamin D were #62.4 nmol/L (25 ng/mL) in all 42 infants in whom they were determined. All infants responded to therapy of limited duration with 1 or more of the following: calcium supplements, calcitriol, low phosphorus formula, and magnesium supplementation. Neuroimaging did not affect management decisions in any neonate.
Neonatal hypocalcemia is a potentially life-threatening condition, with reported prevalence varying by gestational age, maternal and infant comorbidities, and perinatal factors. 1 Because of the higher concentrations of calcium in neonates (up to 1.5 mmol/L, compared with 1.12-1.32 mmol/L in older children and adults), [2] [3] [4] neonatal hypocalcemia is often defined as an ionized calcium ,1.22 mmol/L. 5 Although sometimes clinically silent, it may present with signs of neuromuscular irritability (ranging from myoclonic jerks to seizures), apnea, cyanosis, and/or cardiac rhythm disturbances. 6 Hypocalcemia in this age group has various causes, which are commonly differentiated by the time of onset. Early-onset neonatal hypocalcemia is defined as occurring within the first 4 days of life and is usually secondary to an exaggeration of the normal decline in serum calcium levels in the first 1 to 2 days of life. 7 Late-onset neonatal hypocalcemia usually occurs 5 to 10 days after birth, and the differential includes transient hypoparathyroidism, transient parathyroid hormone (PTH) resistance, DiGeorge syndrome, maternal vitamin D deficiency, malabsorption, intake of formula high in phosphorus content, and hypomagnesemia. [7] [8] [9] There have been few reports regarding infants presenting in acute care settings with seizures or tetany, the etiology of which was later found to be hypocalcemia. [10] [11] [12] [13] [14] [15] [16] [17] In many of these reports, the infants received extensive workups that included cultures of blood, urine, and cerebrospinal fluid; complete blood cell counts; blood chemistries; EEGs; electrocardiograms; and/or neuroimaging studies. To our knowledge, there have been no contemporary largescale studies describing the diagnosis of hypocalcemia in the neonate, especially when limited to transient hypocalcemia. The largest modern case series of which we are aware described 21 Taiwanese infants diagnosed with late-onset hypocalcemia over the span of 12 years. This report limited detailed discussion to those 5 infants who had a final diagnosis of pseudohypoparathyroidism. 17 In the current study, we aim to determine the incidence of moderate-to-severe neonatal hypocalcemia in term neonates without an identified syndromic, cardiacassociated, or iatrogenic etiology and to describe the characteristics of affected infants and the outcomes of their management at our institution. 18 All statistical analyses were performed by using PASW 18 (SPSS Inc, Chicago, IL). Because assumptions of normality were not met, nonparametric (Spearman) tests were used for correlations.
METHODS

Charts
RESULTS
Demographics
The initial search of billing databases yielded 425 neonates. Of these, 347 were excluded from longitudinal analyses for the reasons outlined in Table 1 The median (interquartile range [IQR] ) age at admission for the 78 affected neonates was 8.0 (7.0-10.0) days, and the median duration of admission was 3.0 (2.0-4.0) days. Fifty-six were male (71.8%, vs 58.1% of all neonates admitted to the hospital over the same period, P = .02 [x 2 with Yates correction]). Forty-nine (62.8%) were Hispanic (vs 50.8% of all neonates, P = .04 [Fig 1] ). Eleven of the 78 neonates were infants of mothers with diabetes. All but 2 of the 78 presented with seizure-like activity that was deemed consistent with tetany in the context of low calcium levels. Of the 2 infants who did not present with tetany, 1 presented with decreased urine output (with normal renal function) and the other with cold symptoms and a low-grade fever with a negative sepsis evaluation.
Biochemical Characteristics
Infants were generally severely hypocalcemic, hyperphosphatemic, and hypomagnesemic with low or inappropriately normal PTH responses (reported if checked before any calcium treatment) ( Table 2 ). Levels of 25(OH)D were #62 nmol/L (25 ng/mL) in all 42 infants in whom they were determined, ,50 nmol/L (20 ng/mL) in 35, and ,30 nmol/L (12 ng/mL) in 10.
Sixty-seven infants were exclusively formula-fed, whereas 8 were both formula-fed and breastfed, and only 3 were exclusively breastfed. There were no associations between the type of feeding and any biochemical parameter, including levels of total calcium, ionizedcalcium,phosphorus,magnesium, or 25(OH)D (data not shown).
Total and ionized calcium levels were each significantly correlated with both magnesium and PTH levels, but there was no correlation between magnesium and PTH levels themselves (Table 2 ). There were also no correlations between vitamin D levels and any other biochemical parameters. , but the use of magnesium supplementation did not affect the duration of hospitalization (data not shown). All infants included in this report were followed until they were off all therapies.
Investigative Procedures
Blood and cerebrospinal fluid cultures and neuroimaging studies (head computed tomography scan and/or MRI) showed no clinically significant findings whenever performed (Fig 2) . EEGs were abnormal in 5 of 23 infants. Four of the 5 were started on phenobarbital but rapidly weaned off after seizures were deemed more consistent with hypocalcemic tetany. None of the 5 had recurrent seizures after their hypocalcemia was corrected.
Although we intentionally left children with known syndromic diagnoses out of our analyses, fluorescence in situ hybridization to detect microdeletions of 
FIGURE 1
Demographic characteristics of all neonates with hypocalcemia compared with all neonatal admissions to the same hospital during the same study period. P = .02 for comparison of gender, and P = .04 for comparison of race. chromosome band 22q11.2 was documented negative in 7 of the 78 infants in this study. Conversely, only 1 of 26 infants diagnosed with DiGeorge syndrome at ,31 days of life at our institution over this period initially presented with hypocalcemia.
DISCUSSION
To our knowledge, this study represents the largest reported case series describing infants with late-onset moderate-to-severe transient neonatal hypocalcemia. Our data suggest a prevalence of this condition of ∼0.02% in our population, recognizing that we may have missed infants who remained asymptomatic (unlikely at the calcium thresholds we report), that the 1 smaller children' s hospital in Dallas County may have treated some neonates with this condition, and conversely that our hospital' s catchment area is much larger than Dallas County.
Late maturation of the parathyroid axis is thought to be a predominant cause of transient neonatal hypocalcemia, as suggested by the inappropriately low or normal PTH levels and high phosphorus levels in these infants. 19 These biochemical features may obscure the diagnosis of vitamin D deficiency, which was also common in our neonates, because vitamin D deficiency more commonly presents in older infants and children with low-to-normal phosphorus levels due to secondary hyperparathyroidism (and resultant phosphaturia). These observations extend previous case series of ∼20 patients each in the United States 20 18 At this level, calcium excretion in the urine appears to be normalized, and intestinal calcium transport appears to 
FIGURE 2
The 78 neonates had various combinations of investigative studies performed, with blood culture as the most commonly performed study.
be optimal. 22, 24 By this recent guideline, all of the hypocalcemic infants in our study who had a 25(OH)D level drawn were vitamin D insufficient or worse. These data provide a rationale for the investigation of the vitamin D status of all neonates presenting with moderate-tosevere late-onset neonatal hypocalcemia.
The predominance of formula feeding in our vitamin D-deficient infants (similar to that described in the study by Ashraf et al 20 ) suggests that maternal vitamin D status is the dominant determinant of the infant' s vitamin D status at this age. Indeed, maternal and infant 25(OH)D levels are known to be correlated. 15, 20 It would have been interesting to also know the vitamin D status of the mothers of our patients, but these data were unavailable. Standard practice in our population of pregnant mothers is daily supplementation with a prenatal vitamin that provides 400 IU of vitamin D. 25 There is evidence that this dose is inadequate to maintain vitamin D sufficiency during pregnancy. Hollis et al 22 found that pregnant women supplemented daily with 4000 IU of vitamin D were more likely to achieve a 25(OH)D level .80 nmol/L (32 ng/mL) than women supplemented daily with 2000 or 400 IU of vitamin D. The magnitude of the disparity between the recommendations by Hollis et al 22 and our current practice suggests a high likelihood of vitamin D deficiency in our mothers and their offspring. It would be worthwhile to investigate whether higher doses of maternal vitamin D supplementation in our population might achieve vitamin D sufficiency and thereby play a role in decreasing the prevalence of late-onset neonatal hypocalcemia.
Whereas the relatively high frequency of Hispanic infants in our series might be explained by a greater prevalence of vitamin D deficiency in that population, the predominance of males has not been previously reported, and an explanation for this observation is not obvious. Available data do not allow us to distinguish between gender-specific differences (at least in our population) in such factors as neonatal vitamin D levels, PTH secretion, or dietary calcium absorption or an ascertainment bias due to increased susceptibility of males to hypocalcemic seizures. We found no differences in the vitamin D levels of males versus females (data not shown).
Population-based studies might be able to address some of these possibilities.
Although a seasonal variation in the incidence of neonatal hypocalcemia (ie, decreased incidence in summer months) would support an etiologic role for vitamin D deficiency in the pathogenesis of late-onset neonatal hypocalcemia, our data did not show seasonal variations in either vitamin D levels or incidence of hypocalcemia (not shown). This is consistent with the observed lack of seasonal variation in vitamin D levels in our obesity clinic population, particularly among Hispanic and African American patients, which may reflect lifestyle choices in our locale that limit sun exposure. 26 In addition to the high prevalence of vitamin D deficiency, 75 of 78 infants were also hypomagnesemic, a wellrecognized risk factor for hypocalcemia. 27 It is noteworthy but not surprising that magnesium and PTH levels were not correlated in our patients. Magnesium is necessary for both PTH secretion and peripheral responsiveness to PTH, 27 and decreased PTH secretion due to hypomagnesemia may have been partially counterbalanced by compensatory increases in PTH secretion in response to hypocalcemia caused by alterations in responsiveness to PTH. 3 , magnesium (IV and/or oral), and a formula low in phosphorus for a short duration of 1 to 2 months appears to be effective in treating neonates presenting with late-onset hypocalcemia.
CONCLUSIONS
Moderate-to-severe late-onset neonatal hypocalcemia is more common in Hispanic and male infants, is usually a sign of coexistent vitamin D deficiency and hypomagnesemia, and is readily managed with therapy of limited duration.
Neonates presenting with seizures who have moderate-to-severe hypocalcemia but no other causes for concern are unlikely to benefit from studies to screen for DiGeorge syndrome or from neuroimaging studies. Yes, emphasis on calcitriol Inferred in recommendation to aim for 4:1 molar ratio of calcium to phosphorus in formula Endocrinology 35 Yes, emphasis on calcitriol Inferred in recommendation to aim for 3-4:1 molar ratio of calcium to phosphorus in formula
All texts advocate treatment with calcium in oral and/or IV formulations.
